Compare BCAL & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BCAL | THW |
|---|---|---|
| Founded | 2001 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Finance Companies |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.3M | 513.9M |
| IPO Year | 2020 | 2015 |
| Metric | BCAL | THW |
|---|---|---|
| Price | $19.02 | $12.86 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $20.67 | N/A |
| AVG Volume (30 Days) | ★ 138.5K | 91.0K |
| Earning Date | 04-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 777.27 | N/A |
| EPS | ★ 0.42 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.67 | N/A |
| P/E Ratio | $45.26 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.07 | $10.13 |
| 52 Week High | $20.47 | $13.19 |
| Indicator | BCAL | THW |
|---|---|---|
| Relative Strength Index (RSI) | 56.39 | 54.73 |
| Support Level | $18.49 | $12.33 |
| Resistance Level | $19.26 | $12.84 |
| Average True Range (ATR) | 0.35 | 0.16 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 68.09 | 50.00 |
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.